Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Fox Chase Cancer Center Identifier:
First received: January 7, 2005
Last updated: July 9, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)